Whilst somatic KRAS and NRAS mutations are frequently found in AML, mutations in other RAS signalling pathway genes, including NF1, occur at lower frequencies, although the reported frequency for NF1 somatic mutations ranges quite widely from 3.5 to 23.6% [79, 82–85]. This evidence concerns the gene NF1 and acute myeloid leukemia.